Results 21 to 30 of about 8,706 (198)

Review of methods and antimicrobial agents for susceptibility testing against Pythium insidiosum

open access: yesHeliyon, 2020
Pythiosis is a life-threatening infectious disease of humans and animals caused by the oomycete microorganism Pythium insidiosum. The disease has been increasingly diagnosed worldwide. P. insidiosum inhabits freshwater and presents in two forms: mycelium
Theerapong Krajaejun, Hanna Yolanda
exaly   +3 more sources

Highly sensitive multiplex PCR for convenient quantification and differentiation of canine Oomycota pathogens: Pythium insidiosum, Lagenidium giganteum f. caninum, and Paralagenidium karlingii [PDF]

open access: yesMicrobiology Spectrum
Oomycota mammalian pathogens, including Pythium (P.) insidiosum, Lagenidium (L.) giganteum f. caninum, and Paralagenidium (Para.) karlingii, are increasingly recognized as causes of life-threatening infections in dogs, with diagnosis complicated by their
Asfiha Tarannum   +8 more
doaj   +2 more sources

Bone lesions caused byPythium insidiosumin a horse

open access: yesMedical Mycology, 1988
A 5-year-old, female saddle horse developed a tumoral mass anterolaterally on the metacarpal region of its right front leg. Histopathological study showed hyaline, aseptate, broad hyphae in the sequestered coral-like necrotic masses. Radiographs revealed an extensive osteomyelitis with disorganized bone proliferation of the metacarpal bones, as well as
MENDOZA, L.   +2 more
openaire   +4 more sources

Activity Against Pythium insidiosum and Isolated Constituents of Cordia insignis Roots. [PDF]

open access: yesChem Biodivers
This study investigates the roots of Cordia insignis in search of novel treatments for pythiosis, caused by the oomycete Pythium insidiosum. Seven compounds are isolated, including steroids, a saponin, a coumarin, a fatty acid, and a glycoside, the latter two are reported for the first time in the genus.
de Oliveira RC   +8 more
europepmc   +2 more sources

Pythium insidiosum E PITIOSE

open access: yesVeterinária e Zootecnia, 2023
Pythium insidiosum é o agente etiológico da pitiose, sendo ele um microrganismo da classe dos oomicetos, patogênico e causador da pitiose em várias espécies animais, incluindo humanos. A doença é caracterizada por lesões no tecido cutâneo/subcutâneo, lesões gastrointestinais, vasculares, oculares, podendo se disseminar para órgãos internos.
Rayane Thayse Moreira dos Santos Carnaúba   +5 more
openaire   +1 more source

Identification and genetic characterization of Saprolegnia parasitica, isolated from farmed and wild fish in Finland

open access: yesJournal of Fish Diseases, Volume 46, Issue 8, Page 849-860, August 2023., 2023
Abstract Oomycete infections in farmed fish are one of the most significant disease issues in salmonid aquaculture worldwide. In the present study, Saprolegnia spp. in different farmed fish species in Finland were identified, and the molecular epidemiology of especially Saprolegnia parasitica was examined.
Christine Engblom   +6 more
wiley   +1 more source

Successful management of colonic pythiosis in two dogs in Thailand using antifungal therapy

open access: yesVeterinary Medicine and Science, Volume 8, Issue 6, Page 2283-2291, November 2022., 2022
Successful management of colonic pythiosis in two dogs in Thailand using antifungal therapy. Abstract Gastrointestinal pythiosis is a severe, progressive and often a fatal disease, which is caused by the aquatic pathogen Pythium insidiosum. Treatment is challenging due to the disease's resistance to antifungal drugs.
Pornphan Sukanan   +4 more
wiley   +1 more source

Ex vivo observation of Pythium insidiosum-antigen treated neutrophils on three Pythium insidiosum strains isolated from vascular pythiosis patients. [PDF]

open access: yesHum Vaccin Immunother
The mechanisms of Pythium insidiosum-antigen (PIA) immunotherapy activating a patient’s immune system are unknown. We evaluated the interleukin-8 (IL-8) serum levels during P.
Medhasi S   +6 more
europepmc   +2 more sources

Mechanism of action, resistance, synergism, and clinical implications of azithromycin

open access: yesJournal of Clinical Laboratory Analysis, Volume 36, Issue 6, June 2022., 2022
Azithromycin, sold under the name Zithromax, is classified as a macrolide. It has many benefits due to its immunomodulatory, anti‐inflammatory, and antibacterial effects. Azithromycin mechanism of action including the inhibition of bacterial protein synthesis, inhibition of proinflammatory cytokine production, inhibition of neutrophil infestation, and ...
Mohsen Heidary   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy